Rhythm Pharmaceuticals, Inc. RYTM Operating Lease Right-of-Use Assets in Other Assets
Operating Lease Right-of-Use Assets in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported operating lease right-of-use assets in other assets of $2.94M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets decreased by 12.8% year-over-year, from $3.37M to $2.94M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s operating lease right-of-use assets in other assets has grown at a 11.0% compound annual growth rate (CAGR), from $1.81M to $3.05M.